Show simple item record

PRAME expression is similar in scar and desmoplastic melanoma

dc.contributor.authorPlotzke, Jaclyn M.
dc.contributor.authorZoumberos, Nicholas A.
dc.contributor.authorHrycaj, Steven M.
dc.contributor.authorHarms, Paul W.
dc.contributor.authorBresler, Scott C.
dc.contributor.authorChan, May P.
dc.date.accessioned2022-09-26T16:02:11Z
dc.date.available2023-10-26 12:02:09en
dc.date.available2022-09-26T16:02:11Z
dc.date.issued2022-09
dc.identifier.citationPlotzke, Jaclyn M.; Zoumberos, Nicholas A.; Hrycaj, Steven M.; Harms, Paul W.; Bresler, Scott C.; Chan, May P. (2022). "PRAME expression is similar in scar and desmoplastic melanoma." Journal of Cutaneous Pathology 49(9): 829-832.
dc.identifier.issn0303-6987
dc.identifier.issn1600-0560
dc.identifier.urihttps://hdl.handle.net/2027.42/174781
dc.publisherBlackwell Publishing Ltd.
dc.publisherWiley Periodicals, Inc.
dc.titlePRAME expression is similar in scar and desmoplastic melanoma
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelDermatology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/174781/1/cup14286.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/174781/2/cup14286_am.pdf
dc.identifier.doi10.1111/cup.14286
dc.identifier.sourceJournal of Cutaneous Pathology
dc.identifier.citedreferenceRobson A, Allen P, Hollowood K. S100 expression in cutaneous scars: a potential diagnostic pitfall in the diagnosis of desmoplastic melanoma. Histopathology. 2001; 38 ( 2 ): 135 ‐ 140.
dc.identifier.citedreferenceJackett LA, McCarthy SW, Scolyer RA. SOX10 expression in cutaneous scars: a potential diagnostic pitfall in the evaluation of melanoma re‐excision specimens. Pathology. 2016; 48 ( 6 ): 626 ‐ 628.
dc.identifier.citedreferenceSimpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer. 2005; 5 ( 8 ): 615 ‐ 625.
dc.identifier.citedreferenceLezcano C, Jungbluth AA, Nehal KS, Hollmann TJ, Busam KJ. PRAME expression in melanocytic tumors. Am J Surg Pathol. 2018; 42 ( 11 ): 1456 ‐ 1465.
dc.identifier.citedreferenceLezcano C, Pulitzer M, Moy AP, Hollmann TJ, Jungbluth AA, Busam KJ. Immunohistochemistry for PRAME in the distinction of nodal nevi from metastatic melanoma. Am J Surg Pathol. 2020; 44 ( 4 ): 503 ‐ 508.
dc.identifier.citedreferenceŠekoranja D, Hawlina G, Pižem J. PRAME expression in melanocytic lesions of the conjunctiva. Histopathology. 2021; 79 ( 6 ): 989 ‐ 996.
dc.identifier.citedreferenceGooge PB, Flanigan KL, Miedema JR. Preferentially expressed antigen in melanoma immunostaining in a series of melanocytic neoplasms. Am J Dermatopathol. 2021; 43 ( 11 ): 794 ‐ 800.
dc.identifier.citedreferenceRuby KN, Li Z, Yan S. Aberrant expression of HMB45 and negative PRAME expression in halo nevi. J Cutan Pathol. 2021; 48 ( 4 ): 519 ‐ 525.
dc.identifier.citedreferenceWakefield C, Heffron C. PRAME immunoexpression in benign fibroblasts ‐ a diagnostic pitfall. Histopathology. 2022; 80 ( 6 ): 1011 ‐ 1013.
dc.identifier.citedreferenceSaldanha‐Araujo F, Haddad R, Zanette DL, et al. Cancer/testis antigen expression on mesenchymal stem cells isolated from different tissues. Anticancer Res. 2010; 30 ( 12 ): 5023 ‐ 5027.
dc.identifier.citedreferenceBusam KJ. Cutaneous desmoplastic melanoma. Adv Anat Pathol. 2005; 12 ( 2 ): 92 ‐ 102.
dc.identifier.citedreferenceRamos‐Herberth FI, Karamchandani J, Kim J, Dadras SS. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar. J Cutan Pathol. 2010; 37 ( 9 ): 944 ‐ 952.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.